AOP Health Adopts Veeva’s Full Suite to Streamline Rare Disease Drug Development

Event summary

  • AOP Health is standardizing on Veeva’s Industry Cloud for Life Sciences across R&D, quality, commercial, and data operations.
  • The integration aims to eliminate silos and accelerate delivery of treatments for rare diseases and critical care.
  • AOP Health has operated since 1996, specializing in integrated therapies for unmet medical needs.
  • Veeva serves over 1,500 life sciences customers, from large biopharma to emerging biotechs.

The big picture

AOP Health’s move to Veeva’s full suite reflects a broader industry trend toward end-to-end digital transformation in biopharma. By consolidating its tech stack, AOP Health aims to improve efficiency in rare disease drug development, where speed and regulatory compliance are critical. Veeva’s growing customer base—now over 1,500—highlights the increasing reliance on specialized cloud platforms to manage complex life sciences operations.

What we're watching

Integration Success
How quickly AOP Health can eliminate operational silos and improve cross-functional collaboration.
Time-to-Patient
Whether the Veeva platform will meaningfully accelerate AOP Health’s drug development and commercialization timelines.
Scalability
The pace at which AOP Health can scale its operations globally using Veeva’s unified cloud strategy.